Dana B. Gal

Dana B. Gal

Auto-generated profile, based on publicly available information

Dana B. Gal

Division of Pediatric Cardiology, Department of Pediatrics, Keck School of Medicine at University of Southern California, Los Angeles

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
KMKimberley G. Miles
Kimberley G. Miles
DGDana B. Gal
Dana B. Gal
DFDóra Körmendiné Farkas
Dóra Körmendiné Farkas
KLKristina Laugesen
Kristina Laugesen
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
NMNicolas L. Madsen
Nicolas L. Madsen
BACKGROUND: Over 35% of Danish children with congenital heart disease (CHD) are diagnosed with or treated for a neurodevelopmental or mental health condition. We examined child clinical, parent socioeconomic, and family health factors associated with 4 common diagnostic groups in children with CHD: developmental disorders, intellectual disability, attention-deficit/hyperactivity disorder, and anxiety and mood disorders. METHODS: This population-based cohort study identified children aged <18 years with CHD from 1996 to 2017 by linking individual-level data across Danish health and social registries, excluding children with a neurodevelopmental or mental health diagnosis, by International Classification of Diseases, Tenth Revision codes, before the index date (ie, CHD diagnosis). Using age as a time scale, we computed cumulative incidence by the age of 18 years, incidence rates, and crude and adjusted hazard ratios for each diagnostic group. Hazard ratios were adjusted for child sex and year of CHD diagnosis. In addition, cumulative days in hospital were adjusted for CHD complexity. RESULTS: In 16 473 children with CHD (male, 50.9%; median age at index date, 0.1 [interquartile range, 0.0–1.3] years), the cumulative incidence by the age of 18 years was 7.5% (95% CI, 7.0%–8.1%), 5.0% (95% CI, 4.6%–5.5%), 5.8% (95% CI, 5.3%–6.3%), and 10.3% (95% CI, 9.6%–11.1%) for these 4 diagnostic groups, respectively. Cumulative days in hospital within the first year after CHD diagnosis were the strongest clinical predictor of neurodevelopmental and mental health diagnoses, followed by sex, the presence of a genetic syndrome, and small for gestational age birthweight. Multiple socioeconomic metrics, including maternal or paternal age <25 years, low education (9–10 years), unemployment, and maternal marital status (eg, single or divorced), were predictors, particularly for attention-deficit/hyperactivity disorder and intellectual disability. Maternal and paternal mental health diagnoses were predictors of all 4 diagnostic groups. CONCLUSIONS: We identified clinical, socioeconomic, and parent mental health factors associated with neurodevelopmental and mental health diagnoses in children with CHD. These data may inform early identification of these conditions and guide prevention and resource allocation.

1 November 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
SDSon Q. Duong
Son Q. Duong
YSYuan Shi
Yuan Shi
HGHeather Giacone
Heather Giacone
BNBrittany M. Navarre
Brittany M. Navarre
DGDana B. Gal
Dana B. Gal
CAClaudia A. Algaze
Claudia A. Algaze
Background: Guidelines recommend observation for atrioventricular node recovery until postoperative days (POD) 7 to 10 before permanent pacemaker placement (PPM) in patients with heart block after congenital cardiac surgery. To aid in surgical decision-making for early PPM, we established criteria to identify patients at high risk of requiring PPM. Methods: We reviewed all cases of second degree and complete heart block (CHB) on POD 0 from August 2009 through December 2018. A decision tree model was trained to predict the need for PPM amongst patients with persistent CHB and prospectively validated from January 2019 through March 2021. Separate models were developed for all patients on POD 0 and those without recovery by POD 4. Results: Of the 139 patients with postoperative heart block, 68 required PPM. PPM was associated with older age (3.2 versus 1.0 years; P =0.018) and persistent CHB on POD 0 (versus intermittent CHB or second degree heart block; 87% versus 58%; P =0.001). Median days [IQR] to atrioventricular node recovery was 2 [0–5] and PPM was 9 [6–11]. Of the 100 cases of persistent CHB (21 in the validation cohort), 59 (59%) required PPM. A decision tree model identified 4 risk factors for PPM in patients with persistent CHB: (1) aortic valve replacement, subaortic stenosis repair, or Konno procedure; (2) ventricular L-looping; (3) atrioventricular valve replacement; (4) and absence of preoperative antiarrhythmic agent (in POD 0 model only). The POD 4 model specificity was 0.89 [0.67–0.99] and positive predictive value was 0.94 [95% CI 0.81–0.98], which was stable in prospective validation (positive predictive value 1.0). Conclusions: A data-driven analysis led to actionable criteria to identify patients requiring PPM. Patients with left ventricular outflow tract surgery, atrioventricular valve replacement, or ventricular L-Looping could be considered for PPM on POD 4 to reduce risks of temporary pacing and improve care efficiency.

16 November 2022 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
DGDana B. Gal
Dana B. Gal
CCCaitlin O. Clyde
Caitlin O. Clyde
ECErin L. Colvin
Erin L. Colvin
JCJessica Colyer
Jessica Colyer
AFAnne M. Ferris
Anne M. Ferris
NMNicolas L. Madsen
Nicolas L. Madsen
Background: Pain following surgery for cardiac disease is ubiquitous, and optimal management is important. Despite this, there is large practice variation. To address this, the Paediatric Acute Care Cardiology Collaborative undertook the effort to create this clinical practice guideline.Methods: A panel of experts consisting of paediatric cardiologists, advanced practice practitioners, pharmacists, a paediatric cardiothoracic surgeon, and a paediatric cardiac anaesthesiologist was convened. The literature was searched for relevant articles and Collaborative sites submitted centre-specific protocols for postoperative pain management. Using the modified Delphi technique, recommendations were generated and put through iterative Delphi rounds to achieve consensusResults: 60 recommendations achieved consensus and are included in this guideline. They address guideline use, pain assessment, general considerations, preoperative considerations, intraoperative considerations, regional anaesthesia, opioids, opioid-sparing, non-opioid medications, non-pharmaceutical pain management, and discharge considerations.Conclusions: Postoperative pain among children following cardiac surgery is currently an area of significant practice variability despite a large body of literature and the presence of centre-specific protocols. Central to the recommendations included in this guideline is the concept that ideal pain management begins with preoperative counselling and continues through to patient discharge. Overall, the quality of evidence supporting recommendations is low. There is ongoing need for research in this area, particularly in paediatric populations.
1

29 October 2021 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
DGDana B. Gal
Dana B. Gal
AMAna Morales
Ana Morales
SRSusan Rojahn
Susan Rojahn
TCTom Callis
Tom Callis
JGJohn Garcia
John Garcia
SHSeth A. Hollander
Seth A. Hollander

1 August 2021 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
DGDana B. Gal
Dana B. Gal
NDNatalie Ms Deuitch
Natalie Ms Deuitch
SLSandra Soo Jin Lee
Sandra Soo Jin Lee
RSRosalie Tang Np Simon
Rosalie Tang Np Simon
DCDanton S. Char
Danton S. Char
OBJECTIVES: Through improving diagnostics and prognostics genomic sequencing promises to significantly impact clinical decisions for children with critical cardiac disease. Little is known about how families of children with critical cardiac disease perceive the impact of genomic sequencing on clinical care choices. DESIGN: Qualitative interview study. SETTING: A high-volume, tertiary pediatric heart center. SUBJECTS: Families of children with critical cardiac disease. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Thematic analysis of interview response content. Thirty-five families were interviewed. Three themes emerged: 1) benefits versus challenges of having genomic sequencing results, and 2) fears of clinical applications of genomic sequencing, and 3) nonclinical fears related to genomic sequencing. Participants struggled with perceived uses of genomic sequencing-derived knowledge. They described comfort in foreknowledge of their child’s likely disease course but articulated significant apprehension around participating in care decisions with limited knowledge of genomic sequencing, genomic sequencing uses to inform clinical resource rationing decisions, and genomic sequencing uses by third parties impacting financial pressures families experience caring for a child with critical cardiac disease. CONCLUSIONS: Families’ perceptions of genomic sequencing uses in critical cardiac disease appear to strain their overall trust in the health system. Erosion of trust is concerning because the potential of genomic sequencing in critical cardiac disease will be unrealized if families are unwilling to undergo genomic sequencing, let alone to participate in the ongoing research needed to link genomic sequencing variants to clinical outcomes. Our findings may have implications for genomic sequencing use in children with other critical, high-acuity diseases.

26 September 2022 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
DGDana B. Gal
Dana B. Gal
DCDanton S. Char
Danton S. Char
JAJeffery B. Anderson
Jeffery B. Anderson
DCDavid S. Cooper
David S. Cooper
NMNicolas L. Madsen
Nicolas L. Madsen